Ask Warren

JW Pharmaceutical

001060 · KOSPI · ₩001060 · JW중외제약

₩23,150▼ ₩50 (0.22%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩222B₩200B₩199B₩200B₩191B₩185B₩188B₩179B
Cost of sales₩117B₩101B₩109B₩105B₩100B₩101B₩105B₩92B
Gross profit₩105B₩98B₩90B₩95B₩91B₩84B₩83B₩86B
Operating income₩33B₩34B₩15B₩32B₩25B₩22B₩18B₩27B
Net income₩408M₩27B₩31B₩32B−₩19B₩17B₩45B₩11B
Net income to shareholders₩28B₩27B₩15B₩31B−₩1.9B₩17B₩17B₩20B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩660B₩622B₩605B₩612B₩590B₩611B₩605B₩637B
Current assets₩345B₩309B₩297B₩332B₩325B₩324B₩306B₩361B
Cash and equivalents₩44B₩21B₩39B₩33B₩11B₩32B₩10B₩39B
Total liabilities₩250B₩240B₩236B₩257B₩267B₩280B₩275B₩333B
Current liabilities₩221B₩211B₩209B₩220B₩230B₩219B₩209B₩255B
Borrowings₩50B₩32B₩32B₩45B₩66B₩55B₩67B₩28B
Total equity₩410B₩382B₩369B₩354B₩323B₩331B₩329B₩304B
Shareholders' equity₩410B₩382B₩369B₩354B₩323B₩331B₩329B₩304B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩43B₩17B₩28B₩47B−₩6.7B₩29B₩19B₩11B
Capital spending₩2.3B₩3.2B₩4.9B₩1.2B₩1.4B₩4.3B₩2.9B₩982M
Free cash flow₩40B₩14B₩23B₩46B−₩8B₩24B₩16B₩9.9B
Dividends paid₩31B−₩16B₩22B₩0₩0−₩11B₩0₩0

Consolidated where available. Amounts in won.

Also known as: JW Pharmaceutical / JW중외제약 / 001060 / KRX:001060

Source: KRX statistical information